-- Health care stocks were lower late Monday afternoon with the NYSE Health Care Index easing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.3%.
The iShares Biotechnology ETF (IBB) shed 0.5%.
In corporate news, HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said. RBC reiterated its outperform rating and lowered its price target to $534 from $593. HCA Healthcare shares were up 2.3%.